The term Ribosomal Protein L12 Inhibitors refers to a class of compounds that specifically target and modulate the activity or expression of the Ribosomal Protein L12 (RPL12). RPL12 is an integral component of the ribosome's 60S subunit, playing a critical role in the complex machinery responsible for protein synthesis in cells. Any disturbances or modifications to the function or levels of RPL12 can subsequently affect the overall efficiency and fidelity of protein translation, making the study of its inhibitors of great biochemical interest.
Compounds falling under the category of RPL12 inhibitors can operate through various mechanisms. Some might directly bind to the RPL12 protein, altering its conformation and thus its function within the ribosome. Others might interfere at the genetic level, inhibiting the transcription of the RPL12 gene or blocking its translation into a functional protein. Still, others could operate indirectly by modulating pathways or factors that control the synthesis or degradation of RPL12. Since the ribosome and its associated proteins are highly conserved structures across many species, the specificity of these inhibitors is of paramount importance. A specific inhibitor can be an invaluable tool for researchers aiming to dissect the intricate roles and regulatory mechanisms surrounding RPL12 and ribosomal function as a whole. Understanding the exact mechanism and specificity of these inhibitors can shed light on the broader cellular consequences of perturbing ribosomal function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA, disrupting RNA synthesis and thus potentially inhibiting the expression of RPL12. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis, which might indirectly decrease RPL12 protein levels. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, reducing guanine nucleotide synthesis and possibly affecting RPL12 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase that regulates protein synthesis. This could lead to reduced expression of ribosomal proteins including RPL12. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, leading to reduced nucleotide levels and potentially impacting RPL12 expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, disturbing DNA replication and transcription, which might influence RPL12 gene expression. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
Zebularine inhibits DNA methylation, which may lead to changes in the epigenetic state and influence RPL12 gene transcription. | ||||||
Teniposide | 29767-20-2 | sc-204910 sc-204910A | 25 mg 100 mg | $73.00 $235.00 | 6 | |
Teniposide inhibits DNA topoisomerase II, potentially disrupting DNA replication and transcription, which may reduce RPL12 expression. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone intercalates into DNA and inhibits topoisomerase II, which could lead to reduced transcription of genes like RPL12. | ||||||